Survival of Preventive Care Coverage Mandate Would Boost Some Health Care Firms
-
Apr 25, 2025
Although health insurers don’t have much to lose in a Supreme Court case concerning free preventive care coverage, certain diagnostics companies and pharmaceutical firms are very invested in the outcome. Those firms — and their investors — received a welcome surprise on April 21 when oral arguments in the case known as Kennedy v. Braidwood suggested that the high court will protect one of the Affordable Care Act’s key provisions.
“The court surprisingly seems likely to uphold the constitutionality of the task force, including the appointment of task force members and the supervision by the HHS secretary,” Richard Hughes IV, a health care lawyer at Epstein Becker Green, wrote in an email to clients, reporters and other stakeholders after attending the oral arguments.
Read more© 2025 MMIT

The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.